UTI
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
UTI processes and supplies hardened glass covers, the small protective panes that sit over smartphone camera lenses, for use in mobile devices such as smartphones, tablets, and laptops.
The company is a first-tier supplier to Samsung Electronics, providing camera window cover glass for both premium and mid-range handsets, and is listed on KOSDAQ, South Korea's tech-focused small-cap exchange. Camera window cover glass is its core revenue line, and it also processes ultra-thin 'slimmed' glass and applies hard-coating technology under a strategic alliance with Corning.
Summary is AI-generated and may contain errors · figures from DART filings
UTI has a strategic alliance with Corning, the US glass specialist, through which it received a hard-coating technology transfer and sources Corning Glass for further processing.
UTI in five facts
What does UTI do?
UTI processes and supplies hardened glass covers, the small protective panes that sit over smartphone camera lenses, for use in mobile devices such as smartphones, tablets, and laptops.
Where is UTI listed and in which sector?
UTI (Korean name: 유티아이) trades under KRX code 179900 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Information Technology sector, Components.
How large is UTI?
Its market capitalisation was US$30.6M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were UTI's latest annual revenue and operating profit?
For fiscal year 2025, UTI reported revenue of US$15.1M, an operating loss of US$36.5M and a net loss of US$28.2M, per its annual report on DART (data retrieved from DART on 2026-06-04). Revenue was up 7.6% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-06-04
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Resolution to convene a general shareholders' meeting (extraordinary meeting)Oct 16
- Notice of general shareholders' meetingOct 16
- Conversion price adjustmentSep 22
- Change of CEOSep 8
- DisclosureSep 8
- [Amended] Resolution to convene a general shareholders' meeting (extraordinary meeting)Sep 7
- Conversion price adjustmentSep 7
- [Amended] Material event report (convertible bonds)
UTI updated the terms of convertible bonds to raise US$38.2M, about 108.9% of its market value.
Capital raise · Aug 13 - Subscription results of rights offering or equity-linked bonds (voluntary)
UTI's general public offering rights offering was oversubscribed at a 196.39% subscription rate, with 3,493,700 shares subscribed against 1,778,907 shares offered, with new shares scheduled to list on September 4, 2026.
Capital raise · Aug 12 - Treasury share acquisition: results report
UTI Co., Ltd. reported that on August 7, 2026 it acquired 700,000 treasury common shares as a gratuitous gift from its largest shareholder (no cash purchase price), bringing its total treasury holding to 910,101 shares, 4.60% of the 19,790,412 shares outstanding.
Treasury Shares · Aug 7 - Rights offering: final issue price set
UTI Co., Ltd. finalized the issue price for its 1,778,907-share rights offering (par value US$0.35) at US$1.18 per share on August 6, 2026, applying a 20% discount to the volume-weighted average price for the 3rd to 5th trading days before the general-public subscription date.
Capital raise · Aug 6 - [Amended] Material event report (treasury share acquisition)
UTI Co., Ltd. amended its July 7, 2026 decision to acquire 700,000 treasury common shares via a gratuitous gift from its largest shareholder, extending the acquisition period's end date from August 6, 2026 to August 14, 2026; the company separately already held 210,101 treasury shares (1.1%) as collateral for its 4th exchangeable bonds.
Treasury Shares · Aug 6 · 2 versions - [Amended] Material event report (rights offering)
UTI updated the terms of a public offering to raise US$2.11M, about 6.0% of its market value.
Capital raise · Aug 6 · 2 versions - Material event report (convertible bonds)
UTI disclosed convertible bonds to raise US$1.66M, about 5.0% of its market value.
Capital raise · Jul 8 - Early redemption of convertible bonds (incl. overseas CBs)Capital raise · Jun 29
- Early redemption of convertible bonds (incl. overseas CBs)Capital raise · Jun 1
- [Amended] Material event report (convertible bonds)
UTI updated the terms of convertible bonds to raise US$35.8M, about 108.9% of its market value.
Capital raise · Jun 1 - Early redemption of convertible bonds (incl. overseas CBs)Capital raise · May 29
- [Amended] Material event report (convertible bonds)
UTI updated the terms of convertible bonds to raise US$36M, about 108.9% of its market value.
Capital raise · May 26 - Early redemption of convertible bonds (incl. overseas CBs)Capital raise · May 22
- Material event report (convertible bonds)
UTI disclosed convertible bonds to raise US$6.65M, about 20.1% of its market value.
Capital raise · May 21 - [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies)
UTI updated its previously filed consolidated results for FY2025: revenue of US$13.6M (+7.6% year on year), an operating loss of US$32.9M and a net loss of US$25.4M.
Earnings · Mar 13 · 2 versions - Rights offering (paid-in capital increase) decision (subsidiary)Capital raise · Feb 23
- Decision to acquire shares/equity in another company
UTI disclosed an acquisition of UTI VINA VINH PHUC Co.,Ltd, worth US$10M.
M&A · Feb 23